07/17/2020
U.S. pharmaceutical company Gilead announced last week that its experimental coronavirus treatment, remdesivir, will cost more than $3,000 per patient in the US. That’s at least 33% MORE than any other country in the world, even though our taxes helped pay for the development of the drug!
dave, since you have fought for lower drug prices, you must be OUTRAGED. Gilead and other companies are hoping we won’t notice. You can help make it harder for them to get away with it with this quick action:
Read up on out of control drug prices, for remdesivir and other drugs, during the pandemic. Then, share this post on Facebook to ensure everyone knows what’s going on and will join in and fight this.
And now, here’s the AARP Broadcast for July.
